5 Analysts Have This to Say About IDEXX Laboratories
Portfolio Pulse from Benzinga Insights
In the last quarter, IDEXX Laboratories (NASDAQ:IDXX) received various analyst ratings, with 1 bullish, 2 somewhat bullish, and 2 indifferent. The average 12-month price target for the company is $520.4, representing a 6.84% decrease from the previous average price target of $558.60.
November 03, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
IDEXX Laboratories received mixed analyst ratings, with an average 12-month price target of $520.4, a decrease from the previous target.
The mixed analyst ratings indicate uncertainty about the company's performance. The decrease in the average price target suggests that analysts expect the stock price to decrease in the future, which could negatively impact the stock. However, the presence of bullish ratings also indicates some positive sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100